Understanding How is deruxtecan administered via intravenous infusion
•
4 min read
As a potent antibody-drug conjugate, deruxtecan (brand name Enhertu) requires a precise intravenous (IV) administration protocol to deliver its therapeutic payload effectively to cancer cells. Understanding how is deruxtecan administered is critical for both patients and healthcare providers to ensure proper treatment and safety.
